Ada Gjyrezi

1.2k total citations
15 papers, 833 citations indexed

About

Ada Gjyrezi is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Ada Gjyrezi has authored 15 papers receiving a total of 833 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 7 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in Ada Gjyrezi's work include Prostate Cancer Treatment and Research (7 papers), Cancer, Lipids, and Metabolism (4 papers) and Nanoparticle-Based Drug Delivery (3 papers). Ada Gjyrezi is often cited by papers focused on Prostate Cancer Treatment and Research (7 papers), Cancer, Lipids, and Metabolism (4 papers) and Nanoparticle-Based Drug Delivery (3 papers). Ada Gjyrezi collaborates with scholars based in United States, France and Japan. Ada Gjyrezi's co-authors include Paraskevi Giannakakou, David M. Nanus, Scott T. Tagawa, Daniel Escuín, Matthew S. Loftus, Chantal Chanel‐Vos, Xi Kathy Zhou, Ruoqian Shen, Medha S. Darshan and Maria Thadani‐Mulero and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Ada Gjyrezi

14 papers receiving 824 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ada Gjyrezi United States	9	385	338	236	205	181	15	833
Nicolas Floc’h United Kingdom	14	493 1.3×	587 1.7×	464 2.0×	223 1.1×	57 0.3×	30	1.2k
Bea Pauwels Belgium	16	209 0.5×	439 1.3×	356 1.5×	188 0.9×	45 0.2×	30	949
Yan Hu China	19	105 0.3×	976 2.9×	161 0.7×	303 1.5×	114 0.6×	41	1.3k
Heping Li China	19	141 0.4×	755 2.2×	232 1.0×	503 2.5×	91 0.5×	47	1.2k
Patricia Juárez Mexico	13	140 0.4×	298 0.9×	251 1.1×	99 0.5×	67 0.4×	26	718
Ernst Ulsperger Austria	15	360 0.9×	248 0.7×	572 2.4×	126 0.6×	38 0.2×	45	887
Marilynn Vetzel United States	17	109 0.3×	540 1.6×	483 2.0×	66 0.3×	222 1.2×	28	1.3k
Lynsey A. Huxham Canada	13	85 0.2×	276 0.8×	300 1.3×	147 0.7×	69 0.4×	15	806
Guoqiang Shao China	18	182 0.5×	234 0.7×	206 0.9×	89 0.4×	135 0.7×	71	888
Liteng Lin China	18	111 0.3×	368 1.1×	234 1.0×	163 0.8×	206 1.1×	39	1.1k

Countries citing papers authored by Ada Gjyrezi

Since Specialization

Citations

This map shows the geographic impact of Ada Gjyrezi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ada Gjyrezi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ada Gjyrezi more than expected).

Fields of papers citing papers by Ada Gjyrezi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ada Gjyrezi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ada Gjyrezi. The network helps show where Ada Gjyrezi may publish in the future.

Co-authorship network of co-authors of Ada Gjyrezi

This figure shows the co-authorship network connecting the top 25 collaborators of Ada Gjyrezi. A scholar is included among the top collaborators of Ada Gjyrezi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ada Gjyrezi. Ada Gjyrezi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Zhang, Jiaren, Giuseppe Galletti, Susan Halabi, et al.. (2022). Association of circulating tumor cell RB1 loss RNA signature with outcomes and immune phenotypes in men with mCRPC.. Journal of Clinical Oncology. 40(6_suppl). 139–139.

Gjyrezi, Ada, Giuseppe Galletti, Jiaren Zhang, et al.. (2021). Androgen receptor variant shows heterogeneous expression in prostate cancer according to differentiation stage. Communications Biology. 4(1). 785–785. 5 indexed citations

Galletti, Giuseppe, Chao Zhang, Ada Gjyrezi, et al.. (2020). Microtubule Engagement with Taxane Is Altered in Taxane-Resistant Gastric Cancer. Clinical Cancer Research. 26(14). 3771–3783. 24 indexed citations

Gjyrezi, Ada, Fang Xie, Olga Voznesensky, et al.. (2020). Taxane resistance in prostate cancer is mediated by decreased drug-target engagement. Journal of Clinical Investigation. 130(6). 3287–3298. 38 indexed citations

Worroll, Daniel, Giuseppe Galletti, Ada Gjyrezi, et al.. (2019). Androgen receptor nuclear localization correlates with AR-V7 mRNA expression in circulating tumor cells (CTCs) from metastatic castration resistance prostate cancer patients. Physical Biology. 16(3). 36003–36003. 13 indexed citations

Gjyrezi, Ada, Giuseppe Galletti, Jiaren Zhang, et al.. (2019). Abstract 451: Transferrin Receptor identifies a distinct pool of circulating tumor cells from metastatic prostate cancer patients with unique molecular profiles enriched in AR variants. Cancer Research. 79(13_Supplement). 451–451. 1 indexed citations

Tagawa, Scott T., Emmanuel S. Antonarakis, Ada Gjyrezi, et al.. (2018). Expression of AR-V7 and ARv567es in Circulating Tumor Cells Correlates with Outcomes to Taxane Therapy in Men with Metastatic Prostate Cancer Treated in TAXYNERGY. Clinical Cancer Research. 25(6). 1880–1888. 86 indexed citations

Kanakkanthara, Arun, Anja Wilmes, Aurora O’Brate, et al.. (2011). Peloruside- and Laulimalide-Resistant Human Ovarian Carcinoma Cells Have βI-Tubulin Mutations and Altered Expression of βII- and βIII-Tubulin Isotypes. Molecular Cancer Therapeutics. 10(8). 1419–1429. 33 indexed citations

Darshan, Medha S., Matthew S. Loftus, Maria Thadani‐Mulero, et al.. (2011). Taxane-Induced Blockade to Nuclear Accumulation of the Androgen Receptor Predicts Clinical Responses in Metastatic Prostate Cancer. Cancer Research. 71(18). 6019–6029. 343 indexed citations

10.

Wang, Xu, Jun Li, Yuxiang Wang, et al.. (2011). A Folate Receptor-Targeting Nanoparticle Minimizes Drug Resistance in a Human Cancer Model. ACS Nano. 5(8). 6184–6194. 120 indexed citations

11.

Wang, Xu, Jun Li, Yuxiang Wang, et al.. (2011). Abstract LB-196: A folate receptor-targeted nanoparticle minimizes multidrug resistance in human cancer xenograft model. Cancer Research. 71(8_Supplement). LB–196. 1 indexed citations

12.

Gjyrezi, Ada, Zeynep H. Gümüş, Ilse Van den Wyngaert, et al.. (2010). Abstract 115: An integrated framework of transcriptome analysis leads to mechanistic insights into the FTI/Taxol synergy. Cancer Research. 70(8_Supplement). 115–115. 2 indexed citations

13.

Zhou, Jun, Ada Gjyrezi, Minoru Yoshida, et al.. (2009). The Protein Farnesyltransferase Regulates HDAC6 Activity in a Microtubule-dependent Manner. Journal of Biological Chemistry. 284(15). 9648–9655. 30 indexed citations

14.

Wang, Xu, Jun Li, Yiqing Wang, et al.. (2009). HFT-T, a Targeting Nanoparticle, Enhances Specific Delivery of Paclitaxel to Folate Receptor-Positive Tumors. ACS Nano. 3(10). 3165–3174. 136 indexed citations

15.

Wang, Xu, Ada Gjyrezi, Paraskevi Giannakakou, et al.. (2007). Investigation of taxol-resistance using folate-targeted ternary therapeutic nanoparticle. Cancer Research. 67. 2311–2311. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact